Effect of galantamine on the human alpha7 neuronal nicotinic acetylcholine receptor, the Torpedo nicotinic acetylcholine receptor and spontaneous cholinergic synaptic activity

1. Various types of anticholinesterasic agents have been used to improve the daily activities of Alzheimer's disease patients. It was recently demonstrated that Galantamine, described as a molecule with anticholinesterasic properties, is also an allosteric enhancer of human alpha4beta2 neuronal...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:British journal of pharmacology 2005-07, Vol.145 (5), p.672-678
Hauptverfasser: Texidó, Laura, Ros, Esteve, Martín-Satué, Mireia, López, Susana, Aleu, Jordi, Marsal, Jordi, Solsona, Carles
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 678
container_issue 5
container_start_page 672
container_title British journal of pharmacology
container_volume 145
creator Texidó, Laura
Ros, Esteve
Martín-Satué, Mireia
López, Susana
Aleu, Jordi
Marsal, Jordi
Solsona, Carles
description 1. Various types of anticholinesterasic agents have been used to improve the daily activities of Alzheimer's disease patients. It was recently demonstrated that Galantamine, described as a molecule with anticholinesterasic properties, is also an allosteric enhancer of human alpha4beta2 neuronal nicotinic receptor activity. We explored its effect on the human alpha7 neuronal nicotinic acetylcholine receptor (nAChR) expressed in Xenopus oocytes. 2. Galantamine, at a concentration of 0.1 microM, increased the amplitude of acetylcholine (ACh)-induced ion currents in the human alpha7 nAChR expressed in Xenopus oocytes, but caused inhibition at higher concentrations. The maximum effect of galantamine, an increase of 22% in the amplitude of ACh-induced currents, was observed at a concentration of 250 microM Ach. 3. The same enhancing effect was obtained in oocytes transplanted with Torpedo nicotinic acetylcholine receptor (AChR) isolated from the electric organ, but in this case the optimal concentration of galantamine was 1 microM. In this case, the maximum effect of galantamine, an increase of 35% in the amplitude of ACh-induced currents, occurred at a concentration of 50 microM ACh. 4. Galantamine affects not only the activity of post-synaptic receptors but also the activity of nerve terminals. At a concentration of 1 microM, quantal spontaneous events, recorded in a cholinergic synapse, increased their amplitude, an effect which was independent of the anticholinesterasic activity associated with this compound. The anticholinesterasic effect was recorded in preparations treated with a galantamine concentration of 10 microM. 5. In conclusion, our results show that galantamine enhances human alpha7 neuronal nicotinic ACh receptor activity. It also enhances muscular AChRs and the size of spontaneous cholinergic synaptic events. However, only a very narrow range of galantamine concentrations can be used for enhancing effects.
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_proquest_miscellaneous_67992065</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>67992065</sourcerecordid><originalsourceid>FETCH-LOGICAL-p543-f70bcab86f43ad893cccec9c35a977c4186b4fe23cbc3f3d3f4134cbc0eb6c6b3</originalsourceid><addsrcrecordid>eNqFkMFOwzAMhnsAsTF4BZQTJyqlS9q0RzQNmDSJy-5V6jprUZqEJEXqU_GKlG2cudiy9H229V8lS0qpSLOsLBfJbQgflGZciPwmWWR5yTjnbJl8b5VCiMQqcpRamiiH3iCxhsQOSTcO0hCpXScFMTh6a6Qmpgcb-7kSCRgnDZ3Vv5JHQBetfzq5B-sdtvZfmkjTkuDsfNqgHQO5AP44K2Ey0sWTG_uvPk53ybWSOuD9pa-Sw8v2sHlL9--vu83zPnU5Z6kStAHZlIXiTLZlxQAAoQKWy0oI4FlZNFzhmkEDTLGWKZ4xPg8UmwKKhq2Sx_Na5-3niCHWQx8AtT7_WBeiqta0yGfw4QKOzYBt7Xw_SD_VfwmzHy50fZs</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>67992065</pqid></control><display><type>article</type><title>Effect of galantamine on the human alpha7 neuronal nicotinic acetylcholine receptor, the Torpedo nicotinic acetylcholine receptor and spontaneous cholinergic synaptic activity</title><source>MEDLINE</source><source>Wiley Online Library Journals Frontfile Complete</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>Wiley Free Content</source><source>PubMed Central</source><source>Alma/SFX Local Collection</source><creator>Texidó, Laura ; Ros, Esteve ; Martín-Satué, Mireia ; López, Susana ; Aleu, Jordi ; Marsal, Jordi ; Solsona, Carles</creator><creatorcontrib>Texidó, Laura ; Ros, Esteve ; Martín-Satué, Mireia ; López, Susana ; Aleu, Jordi ; Marsal, Jordi ; Solsona, Carles</creatorcontrib><description>1. Various types of anticholinesterasic agents have been used to improve the daily activities of Alzheimer's disease patients. It was recently demonstrated that Galantamine, described as a molecule with anticholinesterasic properties, is also an allosteric enhancer of human alpha4beta2 neuronal nicotinic receptor activity. We explored its effect on the human alpha7 neuronal nicotinic acetylcholine receptor (nAChR) expressed in Xenopus oocytes. 2. Galantamine, at a concentration of 0.1 microM, increased the amplitude of acetylcholine (ACh)-induced ion currents in the human alpha7 nAChR expressed in Xenopus oocytes, but caused inhibition at higher concentrations. The maximum effect of galantamine, an increase of 22% in the amplitude of ACh-induced currents, was observed at a concentration of 250 microM Ach. 3. The same enhancing effect was obtained in oocytes transplanted with Torpedo nicotinic acetylcholine receptor (AChR) isolated from the electric organ, but in this case the optimal concentration of galantamine was 1 microM. In this case, the maximum effect of galantamine, an increase of 35% in the amplitude of ACh-induced currents, occurred at a concentration of 50 microM ACh. 4. Galantamine affects not only the activity of post-synaptic receptors but also the activity of nerve terminals. At a concentration of 1 microM, quantal spontaneous events, recorded in a cholinergic synapse, increased their amplitude, an effect which was independent of the anticholinesterasic activity associated with this compound. The anticholinesterasic effect was recorded in preparations treated with a galantamine concentration of 10 microM. 5. In conclusion, our results show that galantamine enhances human alpha7 neuronal nicotinic ACh receptor activity. It also enhances muscular AChRs and the size of spontaneous cholinergic synaptic events. However, only a very narrow range of galantamine concentrations can be used for enhancing effects.</description><identifier>ISSN: 0007-1188</identifier><identifier>PMID: 15834443</identifier><language>eng</language><publisher>England</publisher><subject>alpha7 Nicotinic Acetylcholine Receptor ; Animals ; Cholinesterase Inhibitors - pharmacology ; Female ; Galantamine - pharmacology ; Humans ; In Vitro Techniques ; Membrane Potentials - drug effects ; Nootropic Agents - pharmacology ; Oocytes - drug effects ; Parasympathetic Nervous System - drug effects ; Patch-Clamp Techniques ; Receptors, Nicotinic - drug effects ; Synapses - drug effects ; Synaptic Transmission - drug effects ; Torpedo ; Xenopus laevis</subject><ispartof>British journal of pharmacology, 2005-07, Vol.145 (5), p.672-678</ispartof><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/15834443$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Texidó, Laura</creatorcontrib><creatorcontrib>Ros, Esteve</creatorcontrib><creatorcontrib>Martín-Satué, Mireia</creatorcontrib><creatorcontrib>López, Susana</creatorcontrib><creatorcontrib>Aleu, Jordi</creatorcontrib><creatorcontrib>Marsal, Jordi</creatorcontrib><creatorcontrib>Solsona, Carles</creatorcontrib><title>Effect of galantamine on the human alpha7 neuronal nicotinic acetylcholine receptor, the Torpedo nicotinic acetylcholine receptor and spontaneous cholinergic synaptic activity</title><title>British journal of pharmacology</title><addtitle>Br J Pharmacol</addtitle><description>1. Various types of anticholinesterasic agents have been used to improve the daily activities of Alzheimer's disease patients. It was recently demonstrated that Galantamine, described as a molecule with anticholinesterasic properties, is also an allosteric enhancer of human alpha4beta2 neuronal nicotinic receptor activity. We explored its effect on the human alpha7 neuronal nicotinic acetylcholine receptor (nAChR) expressed in Xenopus oocytes. 2. Galantamine, at a concentration of 0.1 microM, increased the amplitude of acetylcholine (ACh)-induced ion currents in the human alpha7 nAChR expressed in Xenopus oocytes, but caused inhibition at higher concentrations. The maximum effect of galantamine, an increase of 22% in the amplitude of ACh-induced currents, was observed at a concentration of 250 microM Ach. 3. The same enhancing effect was obtained in oocytes transplanted with Torpedo nicotinic acetylcholine receptor (AChR) isolated from the electric organ, but in this case the optimal concentration of galantamine was 1 microM. In this case, the maximum effect of galantamine, an increase of 35% in the amplitude of ACh-induced currents, occurred at a concentration of 50 microM ACh. 4. Galantamine affects not only the activity of post-synaptic receptors but also the activity of nerve terminals. At a concentration of 1 microM, quantal spontaneous events, recorded in a cholinergic synapse, increased their amplitude, an effect which was independent of the anticholinesterasic activity associated with this compound. The anticholinesterasic effect was recorded in preparations treated with a galantamine concentration of 10 microM. 5. In conclusion, our results show that galantamine enhances human alpha7 neuronal nicotinic ACh receptor activity. It also enhances muscular AChRs and the size of spontaneous cholinergic synaptic events. However, only a very narrow range of galantamine concentrations can be used for enhancing effects.</description><subject>alpha7 Nicotinic Acetylcholine Receptor</subject><subject>Animals</subject><subject>Cholinesterase Inhibitors - pharmacology</subject><subject>Female</subject><subject>Galantamine - pharmacology</subject><subject>Humans</subject><subject>In Vitro Techniques</subject><subject>Membrane Potentials - drug effects</subject><subject>Nootropic Agents - pharmacology</subject><subject>Oocytes - drug effects</subject><subject>Parasympathetic Nervous System - drug effects</subject><subject>Patch-Clamp Techniques</subject><subject>Receptors, Nicotinic - drug effects</subject><subject>Synapses - drug effects</subject><subject>Synaptic Transmission - drug effects</subject><subject>Torpedo</subject><subject>Xenopus laevis</subject><issn>0007-1188</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2005</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkMFOwzAMhnsAsTF4BZQTJyqlS9q0RzQNmDSJy-5V6jprUZqEJEXqU_GKlG2cudiy9H229V8lS0qpSLOsLBfJbQgflGZciPwmWWR5yTjnbJl8b5VCiMQqcpRamiiH3iCxhsQOSTcO0hCpXScFMTh6a6Qmpgcb-7kSCRgnDZ3Vv5JHQBetfzq5B-sdtvZfmkjTkuDsfNqgHQO5AP44K2Ey0sWTG_uvPk53ybWSOuD9pa-Sw8v2sHlL9--vu83zPnU5Z6kStAHZlIXiTLZlxQAAoQKWy0oI4FlZNFzhmkEDTLGWKZ4xPg8UmwKKhq2Sx_Na5-3niCHWQx8AtT7_WBeiqta0yGfw4QKOzYBt7Xw_SD_VfwmzHy50fZs</recordid><startdate>200507</startdate><enddate>200507</enddate><creator>Texidó, Laura</creator><creator>Ros, Esteve</creator><creator>Martín-Satué, Mireia</creator><creator>López, Susana</creator><creator>Aleu, Jordi</creator><creator>Marsal, Jordi</creator><creator>Solsona, Carles</creator><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>7X8</scope></search><sort><creationdate>200507</creationdate><title>Effect of galantamine on the human alpha7 neuronal nicotinic acetylcholine receptor, the Torpedo nicotinic acetylcholine receptor and spontaneous cholinergic synaptic activity</title><author>Texidó, Laura ; Ros, Esteve ; Martín-Satué, Mireia ; López, Susana ; Aleu, Jordi ; Marsal, Jordi ; Solsona, Carles</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-p543-f70bcab86f43ad893cccec9c35a977c4186b4fe23cbc3f3d3f4134cbc0eb6c6b3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2005</creationdate><topic>alpha7 Nicotinic Acetylcholine Receptor</topic><topic>Animals</topic><topic>Cholinesterase Inhibitors - pharmacology</topic><topic>Female</topic><topic>Galantamine - pharmacology</topic><topic>Humans</topic><topic>In Vitro Techniques</topic><topic>Membrane Potentials - drug effects</topic><topic>Nootropic Agents - pharmacology</topic><topic>Oocytes - drug effects</topic><topic>Parasympathetic Nervous System - drug effects</topic><topic>Patch-Clamp Techniques</topic><topic>Receptors, Nicotinic - drug effects</topic><topic>Synapses - drug effects</topic><topic>Synaptic Transmission - drug effects</topic><topic>Torpedo</topic><topic>Xenopus laevis</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Texidó, Laura</creatorcontrib><creatorcontrib>Ros, Esteve</creatorcontrib><creatorcontrib>Martín-Satué, Mireia</creatorcontrib><creatorcontrib>López, Susana</creatorcontrib><creatorcontrib>Aleu, Jordi</creatorcontrib><creatorcontrib>Marsal, Jordi</creatorcontrib><creatorcontrib>Solsona, Carles</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>MEDLINE - Academic</collection><jtitle>British journal of pharmacology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Texidó, Laura</au><au>Ros, Esteve</au><au>Martín-Satué, Mireia</au><au>López, Susana</au><au>Aleu, Jordi</au><au>Marsal, Jordi</au><au>Solsona, Carles</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Effect of galantamine on the human alpha7 neuronal nicotinic acetylcholine receptor, the Torpedo nicotinic acetylcholine receptor and spontaneous cholinergic synaptic activity</atitle><jtitle>British journal of pharmacology</jtitle><addtitle>Br J Pharmacol</addtitle><date>2005-07</date><risdate>2005</risdate><volume>145</volume><issue>5</issue><spage>672</spage><epage>678</epage><pages>672-678</pages><issn>0007-1188</issn><abstract>1. Various types of anticholinesterasic agents have been used to improve the daily activities of Alzheimer's disease patients. It was recently demonstrated that Galantamine, described as a molecule with anticholinesterasic properties, is also an allosteric enhancer of human alpha4beta2 neuronal nicotinic receptor activity. We explored its effect on the human alpha7 neuronal nicotinic acetylcholine receptor (nAChR) expressed in Xenopus oocytes. 2. Galantamine, at a concentration of 0.1 microM, increased the amplitude of acetylcholine (ACh)-induced ion currents in the human alpha7 nAChR expressed in Xenopus oocytes, but caused inhibition at higher concentrations. The maximum effect of galantamine, an increase of 22% in the amplitude of ACh-induced currents, was observed at a concentration of 250 microM Ach. 3. The same enhancing effect was obtained in oocytes transplanted with Torpedo nicotinic acetylcholine receptor (AChR) isolated from the electric organ, but in this case the optimal concentration of galantamine was 1 microM. In this case, the maximum effect of galantamine, an increase of 35% in the amplitude of ACh-induced currents, occurred at a concentration of 50 microM ACh. 4. Galantamine affects not only the activity of post-synaptic receptors but also the activity of nerve terminals. At a concentration of 1 microM, quantal spontaneous events, recorded in a cholinergic synapse, increased their amplitude, an effect which was independent of the anticholinesterasic activity associated with this compound. The anticholinesterasic effect was recorded in preparations treated with a galantamine concentration of 10 microM. 5. In conclusion, our results show that galantamine enhances human alpha7 neuronal nicotinic ACh receptor activity. It also enhances muscular AChRs and the size of spontaneous cholinergic synaptic events. However, only a very narrow range of galantamine concentrations can be used for enhancing effects.</abstract><cop>England</cop><pmid>15834443</pmid><tpages>7</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0007-1188
ispartof British journal of pharmacology, 2005-07, Vol.145 (5), p.672-678
issn 0007-1188
language eng
recordid cdi_proquest_miscellaneous_67992065
source MEDLINE; Wiley Online Library Journals Frontfile Complete; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; Wiley Free Content; PubMed Central; Alma/SFX Local Collection
subjects alpha7 Nicotinic Acetylcholine Receptor
Animals
Cholinesterase Inhibitors - pharmacology
Female
Galantamine - pharmacology
Humans
In Vitro Techniques
Membrane Potentials - drug effects
Nootropic Agents - pharmacology
Oocytes - drug effects
Parasympathetic Nervous System - drug effects
Patch-Clamp Techniques
Receptors, Nicotinic - drug effects
Synapses - drug effects
Synaptic Transmission - drug effects
Torpedo
Xenopus laevis
title Effect of galantamine on the human alpha7 neuronal nicotinic acetylcholine receptor, the Torpedo nicotinic acetylcholine receptor and spontaneous cholinergic synaptic activity
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-25T07%3A04%3A38IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Effect%20of%20galantamine%20on%20the%20human%20alpha7%20neuronal%20nicotinic%20acetylcholine%20receptor,%20the%20Torpedo%20nicotinic%20acetylcholine%20receptor%20and%20spontaneous%20cholinergic%20synaptic%20activity&rft.jtitle=British%20journal%20of%20pharmacology&rft.au=Texid%C3%B3,%20Laura&rft.date=2005-07&rft.volume=145&rft.issue=5&rft.spage=672&rft.epage=678&rft.pages=672-678&rft.issn=0007-1188&rft_id=info:doi/&rft_dat=%3Cproquest_pubme%3E67992065%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=67992065&rft_id=info:pmid/15834443&rfr_iscdi=true